In an adult patient with known metastatic cancer presenting with unilateral arm swelling, what is the appropriate diagnostic and initial management approach?

Unilateral Arm Swelling in Metastatic Cancer

In a patient with metastatic cancer presenting with unilateral arm swelling, immediately suspect deep venous thrombosis (DVT) as the primary diagnosis and initiate venous ultrasound imaging urgently—if clinical suspicion is high and no contraindications exist, start anticoagulation empirically while awaiting imaging results 1.

Diagnostic Approach

Initial Clinical Assessment

The key presenting features that should raise immediate concern for DVT include 1:

• Unilateral extremity swelling (present in 80% of DVT cases)
• Heaviness or pain in the affected arm (75% of cases)
• Unexplained persistent cramping
• Erythema (26% of cases)
• Swelling in face, neck, or supraclavicular space (suggests central venous involvement)
• Catheter dysfunction if a central line is present

Critical pitfall: Classic DVT symptoms are NOT present in all cases, so maintain a low threshold for investigation in any cancer patient with unilateral arm swelling 1.

Immediate Workup

Order the following tests concurrently 1:

• Venous ultrasound (preferred initial imaging modality)
• CBC with platelet count
• PT/aPTT
• Fibrinogen level
• Liver and kidney function tests (essential for anticoagulation dosing decisions)

If Initial Ultrasound is Negative or Indeterminate

When clinical suspicion remains high despite negative initial imaging 1:

1. Repeat venous ultrasound in 1 week (two normal ultrasounds 1 week apart can exclude progressive DVT)
2. Consider contrast-enhanced CT venography (particularly superior for detecting pelvic vein and IVC thrombus)
3. Consider MRV with contrast (higher sensitivity for proximal DVT, better for iliofemorocaval assessment)

Important consideration: CT venography may be immediately preferable if you suspect central venous obstruction (supraclavicular swelling, facial edema) as it better visualizes central vessels than ultrasound 1.

Alternative Diagnoses to Consider

While DVT is the primary concern requiring urgent exclusion, also consider 2, 3:

Lymphedema

• Can occur even on the "unaffected" side in cancer patients
• May develop without direct lymphatic injury
• Requires lymphoscintigraphy for definitive diagnosis
• Found in 29% (2/7) of breast cancer patients with contralateral arm swelling in one series 2

Tumor-Related Venous Compression

• Rapidly enlarging masses can compress veins without frank thrombosis
• Bedside Doppler ultrasound can demonstrate internal vascular flow patterns to distinguish tumor from hematoma 4
• May require repeat contrast-enhanced CT if initial imaging is ambiguous

Direct Metastatic Disease

• Rare but documented: skeletal muscle metastases can present as isolated arm swelling 5
• Consider if swelling is localized rather than diffuse
• May require tissue biopsy if imaging is atypical for DVT or lymphedema

Initial Management Algorithm

If DVT is Confirmed or Highly Suspected

Start anticoagulation immediately using cancer-specific regimens 1:

First-line options (Category 1 evidence):

• Apixaban: 10 mg PO twice daily × 7 days, then 5 mg twice daily
• Rivaroxaban: 15 mg PO twice daily × 21 days, then 20 mg daily
• LMWH monotherapy:
  • Dalteparin 200 units/kg SC daily, OR
  • Enoxaparin 1 mg/kg SC every 12 hours

Special consideration: For patients with gastric or gastroesophageal tumors, apixaban is safer than edoxaban or rivaroxaban due to lower hemorrhage risk 1.

If DOACs and standard LMWH are unavailable:

• Edoxaban: Initial LMWH/UFH × 5 days, then 60 mg PO daily
• Dabigatran: Initial LMWH/UFH × 5 days, then 150 mg PO every 12 hours

If Imaging Shows No DVT but Lymphedema is Suspected

• Proceed with lymphoscintigraphy for confirmation 2
• Initiate conservative lymphedema management (compression, elevation, physical therapy)
• Rule out central venous obstruction with cross-sectional imaging if symptoms are severe

If All Vascular Studies are Normal

Consider less common etiologies:

• Obtain cross-sectional imaging (CT or MRI) to evaluate for soft tissue metastases 5
• Assess for generalized edema from chemotherapy, hypoalbuminemia, or cardiac/renal dysfunction 2

Key Clinical Pearls

Do not wait for imaging if DVT suspicion is high: Early empiric anticoagulation while awaiting results is appropriate in cancer patients without contraindications 1.

Cancer patients have unique DVT risk: The threshold for investigation should be lower than in non-cancer patients, as malignancy itself is prothrombotic 1, 3.

Bilateral symptoms do not exclude unilateral pathology: Some patients develop contralateral lymphedema or have concurrent bilateral DVT 2.

Bedside ultrasound is invaluable: Point-of-care Doppler can rapidly distinguish vascular flow patterns and guide urgent decision-making 4.